Insta
Test tubes are seen in front of a displayed Sinovac logo in this illustration taken, May 21, 2021. REUTERS/Dado Ruvic/Illustration/File Photo
Singapore's top health officials have cast doubt on the efficacy of the Chinese company Sinovac's COVID-19 vaccines, even though the island nation has begun the use of the same to protect its population against the disease, reports Hindustan Times.
Singapore's Director of Medical Services Kenneth Mak cited the case of Indonesia and said that he was worried about the reports of people vaccinated with Sinovac's vaccine getting sick with the disease.
This comes as the Indonesian officials had earlier this week revealed that more than 350 doctors and medical workers have been infected and dozens hospitalised despite being vaccinated with Sinovac, raising concerns about the vaccine against more infectious variants.
While most of these workers were asymptomatic, dozens of others were hospitalised with high fevers and falling oxygen-saturation levels as per the details shared by a senior health official in Central Java.
It should be noted that Indonesian healthcare workers were among the first to be inoculated against the virus with Sinovac's vaccine when the vaccination started in the country in January.
Support Swarajya's 50 Ground Reports Project & Sponsor A Story
Every general election Swarajya does a 50 ground reports project.
Aimed only at serious readers and those who appreciate the nuances of political undercurrents, the project provides a sense of India's electoral landscape. As you know, these reports are produced after considerable investment of travel, time and effort on the ground.
This time too we've kicked off the project in style and have covered over 30 constituencies already. If you're someone who appreciates such work and have enjoyed our coverage please consider sponsoring a ground report for just Rs 2999 to Rs 19,999 - it goes a long way in helping us produce more quality reportage.
You can also back this project by becoming a subscriber for as little as Rs 999 - so do click on this links and choose a plan that suits you and back us.
Click below to contribute.
Latest